购物车
- 全部删除
- 您的购物车当前为空
TMIFRY8XAG (4-oxo-1,4-dihydroquinoline-2-carboxylic acid) 是 Zerumbone 的衍生物,对 HeLa 癌细胞具有潜在的抗肿瘤作用。
TMIFRY8XAG (4-oxo-1,4-dihydroquinoline-2-carboxylic acid) 是 Zerumbone 的衍生物,对 HeLa 癌细胞具有潜在的抗肿瘤作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 378 | 现货 | |
5 mg | ¥ 537 | 现货 | |
10 mg | ¥ 767 | 现货 | |
25 mg | ¥ 1,378 | 现货 | |
50 mg | ¥ 1,957 | 现货 | |
100 mg | ¥ 2,936 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 464 | 现货 |
产品描述 | TMIFRY8XAG (4-oxo-1,4-dihydroquinoline-2-carboxylic acid) is a derivative of Zerumbone with potential anti-tumor effects towards HeLa cancer cells. |
别名 | 4-oxo-1,4-dihydroquinoline-2-carboxylic acid, 4,4,-二(4-氟苯)氯丁烷, 1,1'-(4-CHLOROBUTYLIDENE)BIS(4-FLUOROBENZENE) |
分子量 | 280.74 |
分子式 | C16H15ClF2 |
CAS No. | 3312-04-7 |
Smiles | FC1=CC=C(C=C1)C(CCCCl)C1=CC=C(F)C=C1 |
密度 | 1.2 g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 9 mg/mL (32.06 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
评论内容